Furthermore, ASB2, MEIS2, and SRPX had significantly lower expression in high‐risk tumors compared to intermediate or low risk, suggesting these genes could be crucial indicators of PCa progression. The gene discussed is MEIS2; the disease is posterior cortical atrophy.